In response to Letter to the Editor "Danger of highlighting the use of coxibs in daily dental practice"
- PMID: 31230774
- DOI: 10.1016/j.ijom.2019.06.018
In response to Letter to the Editor "Danger of highlighting the use of coxibs in daily dental practice"
Comment on
-
Evaluation of the efficacy of celecoxib and ibuprofen on postoperative pain, swelling, and mouth opening after surgical removal of impacted third molars: a randomized, controlled clinical trial.Int J Oral Maxillofac Surg. 2019 Oct;48(10):1348-1354. doi: 10.1016/j.ijom.2019.02.006. Epub 2019 Mar 8. Int J Oral Maxillofac Surg. 2019. PMID: 30853212 Clinical Trial.
-
Danger of highlighting the use of coxibs in daily dental practice.Int J Oral Maxillofac Surg. 2019 Dec;48(12):1608. doi: 10.1016/j.ijom.2019.06.020. Epub 2019 Jun 21. Int J Oral Maxillofac Surg. 2019. PMID: 31230772 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources